Sensus Healthcare (SRTS) Cash from Operations (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sensus Healthcare | 47.41 Mn | 29.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70.05% |
| Dec 31, 2025 | -196.17% |
| Sep 30, 2025 | -26.37% |
| Jun 30, 2025 | 216.44% |
| Mar 31, 2025 | -223.70% |
| Dec 31, 2024 | -120.92% |
| Sep 30, 2024 | -6.55% |
| Jun 30, 2024 | 151.67% |
| Mar 31, 2024 | -406.86% |
| Dec 31, 2023 | 503.62% |
| Sep 30, 2023 | -40.43% |
| Jun 30, 2023 | 112.37% |
| Mar 31, 2023 | 40.70% |
| Dec 31, 2022 | -371.64% |
| Sep 30, 2022 | 96.36% |
| Jun 30, 2022 | -38.48% |
| Mar 31, 2022 | 273.15% |
| Dec 31, 2021 | -242.06% |
| Sep 30, 2021 | -7.60% |
| Jun 30, 2021 | 221.61% |
| Mar 31, 2021 | -209.72% |
| Dec 31, 2020 | 86.37% |
| Sep 30, 2020 | -223.82% |
| Jun 30, 2020 | 391.47% |
| Mar 31, 2020 | -5.64% |
| Dec 31, 2019 | 128.30% |
| Sep 30, 2019 | -126.31% |
| Jun 30, 2019 | 186.77% |
| Mar 31, 2019 | -330.71% |
| Dec 31, 2018 | 25.61% |
| Sep 30, 2018 | -83.24% |
| Jun 30, 2018 | 65.14% |
| Mar 31, 2018 | -537.47% |
| Dec 31, 2017 | 186.90% |
| Sep 30, 2017 | -1,406.69% |
| Jun 30, 2017 | 97.89% |